Characterizing the Bone Marrow Environment in Advanced-Stage Myelofibrosis during Ruxolitinib Treatment Using PET/CT and MRI: A Pilot Study

Current diagnostic criteria for myelofibrosis are largely based on bone marrow (BM) biopsy results. However, these have several limitations, including sampling errors. Explorative studies have indicated that imaging might form an alternative for the evaluation of disease activity, but the heterogene...

全面介紹

書目詳細資料

發表在:	Tomography
Main Authors:	Stefanie Slot, Cristina Lavini, Gerben J. C. Zwezerijnen, Bouke J. H. Boden, J. Tim Marcus, Marc C. Huisman, Maqsood Yaqub, Ellis Barbé, Mariëlle J. Wondergem, Josée M. Zijlstra, Sonja Zweegman, Pieter G. Raijmakers
格式:	Article
語言:	英语
出版:	MDPI AG 2023-02-01
主題:	myelofibrosis MRI PET/CT diagnostic accuracy ruxolitinib
在線閱讀:	https://www.mdpi.com/2379-139X/9/2/38